Biological characteristics of NK cells and their application in cancer treatment

Authors

  • Zhongyong Yu

DOI:

https://doi.org/10.54097/yddbck83

Keywords:

Cancer, immunotherapy, NK cells.

Abstract

The leading cause of mortality among people is cancer. Traditional medicine, however, has significant dangers and negative effects. Because of its great effectiveness, lack of side effects, and safety, cellular immunotherapy has been utilized extensively in the treatment of malignancies in recent years. While various treatment options have many benefits, they also present unique issues and difficulties. In certain ways, NK cell immunotherapy can make up for these deficiencies. It is not necessary to rely on the patient's distinct immune cells because they may be made from allogeneic cells. Additionally, it can successfully cure the majority of solid tumours, get rid of cancer cells that are resistant to chemotherapy and radiation treatment and metastasis, and enhance the body's immune system, which is the present study's emphasis. As a result, this article begins by introducing the basic traits of NK cells, including traits, uses, activation methods, and how NK cells destroy other cells in an immune response. The use of NK cell therapy in treating different cancers, including hematological malignancies, is then emphasized. Finally, NK cell treatment for cancer development and potential issues are examined. In the future, it will serve as a reference for the treatment of tumours.

Downloads

Download data is not yet available.

References

Wade Chun-Wai, et al. Natural Killer Cell-Based Cancer Immunotherapy: A Review on 10 Years Completed Clinical Trials, Cancer Investigation, 2018, 36(8): 431-457.

Shin E, et al. Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. Front. Immunol., 2023, 14: 1192907.

Carissa Dege, et al. Ontogeny As a Critical Determinant of Natural Killer Cell Potential and Function. Blood, 2018, 132: 1271-1271.

Marisa Market, et al. Preventing surgery-induced NK cell dysfunction using anti-TGF-β immunotherapeutics. International Journal of Molecular Sciences, 2022, 23(23): 14608.

Xue Yao, et al. Chemokine networks modulating natural killer cell trafficking to solid tumors. Cytokine & Growth Factor Reviews, 2021, 59(1).

Velichinskii R.A., et al. The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumours. Int. J. Mol. Sci., 2021, 22: 11385.

Beldi-Ferchiou A, et al. Control of NK cell activation by immune checkpoint molecules. International journal of molecular sciences, 2017, 18(10): 2129.

Wang X, et al. Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential. Experimental Hematology & Oncology, 2022, 11(1): 1-19.

Yu M, et al. Development of GPC3-specific chimeric antigen receptor-engineered natural killer cells for the treatment of hepatocellular carcinoma. Mol Ther, 2018, 26: 366-378.

Dong Kuiliang, et al. Analysis of the changes of T lymphocyte subsets, B lymphocyte and NK cell in different types of acute leukemia in different periods. Contemporary Medicine, 2021, 27(5): 592: 70-72.

Reina-Ortiz C., et al. Harnessing the potential of NK Cell-based immunotherapies against multiple myeloma. Cells, 2022, 11: 392.

Fares J, et al. Advances in NK cell therapy for brain tumours. NPJ Precision Oncology, 2023, 7(1): 17.

Downloads

Published

29-12-2023

How to Cite

Yu, Z. (2023). Biological characteristics of NK cells and their application in cancer treatment. Highlights in Science, Engineering and Technology, 74, 672-676. https://doi.org/10.54097/yddbck83